CXCR4 and neoplasm: Numerous studies have demonstrated a role for CXCR4 in mediating tumour cell proliferation, through the use of CXCR4 antagonists AMD3100, peptide R and PRX177561, or by downregulating CXCR4 expression [114,117,120,121,125,126,127].